INS and Hyperglycemia: The elevated expression of CaV3.1 channels not only impairs both basal insulin release and first-phase glucose-stimulated insulin secretion with no influence on second-phase insulin response but also disables islets from normalizing hyperglycemia in STZ-induced diabetic rats.